Scipher Medicine is broadening its focus beyond diagnostics to drive precision medicine development. The company leverages the largest non-oncology clinical transcriptomic dataset, secured through extensive data-sharing agreements with pharma and informatics firms. Strategic partnerships, such as with health data company Savant Bio, enable enhanced clinicogenomic datasets in rheumatoid arthritis. Scipher aims to emulate oncology companies' success in integrating molecular testing with biomarker and drug discovery across immunology and other disease areas.